adjuvant immunotherapy

DRUG4 trials

Sponsors

RenJi Hospital, Sun Yat-sen University, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Conditions

De-escaltion TherapyEsophageal Squamous Cell Carcinoma (ESCC)Muscle Invasive Upper Tract Urothelial CarcinomaNasopharyngeal CarcinomaSquamous Cell Carcinoma of the Head and Neck

Phase 3

Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma

RecruitingNCT05877872

Sun Yat-sen UniversityDe-escaltion Therapy, Nasopharyngeal Carcinoma

Start: 2023-05-20End: 2029-03-30Target: 424Updated: 2023-05-26

De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Not yet recruitingNCT07320690

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversitySquamous Cell Carcinoma of the Head and Neck

Start: 2026-01-01End: 2031-07-01Target: 356Updated: 2026-01-06

Unknown Phase

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma

RecruitingNCT05595408

RenJi HospitalMuscle Invasive Upper Tract Urothelial Carcinoma

Start: 2022-02-01End: 2026-12-31Target: 84Updated: 2025-12-09

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

Active, not recruitingNCT06762158

RenJi HospitalEsophageal Squamous Cell Carcinoma (ESCC)

Start: 2024-10-30End: 2029-12-01Target: 50Updated: 2025-01-07